Poseida Therapeutics (PSTX)
(Delayed Data from NSDQ)
$3.51 USD
+0.13 (3.85%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $3.52 +0.01 (0.28%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.42 | 0.00% |
Earnings Summary
For their last quarter, Poseida Therapeutics (PSTX) reported earnings of -$0.32 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive earnings surprise of 25.58%. Look out for PSTX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.42 per share, reflecting a year-over-year decrease of 20%.
Earnings History
Price & Consensus
Zacks News for PSTX
Are You Looking for a Top Momentum Pick? Why Poseida Therapeutics, Inc. (PSTX) is a Great Choice
PSTX: What are Zacks experts saying now?
Zacks Private Portfolio Services